Pharmacogenomic Testing in Current Clinical Practice: Implementation in the Clinical Laboratory

Author:   Alan H. B. Wu ,  Kiang-Teck J. Yeo
Publisher:   Humana Press Inc.
Edition:   2011 ed.
ISBN:  

9781617797262


Pages:   272
Publication Date:   19 April 2013
Format:   Paperback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $316.77 Quantity:  
Add to Cart

Share |

Pharmacogenomic Testing in Current Clinical Practice: Implementation in the Clinical Laboratory


Add your own review!

Overview

Full Product Details

Author:   Alan H. B. Wu ,  Kiang-Teck J. Yeo
Publisher:   Humana Press Inc.
Imprint:   Humana Press Inc.
Edition:   2011 ed.
Dimensions:   Width: 15.50cm , Height: 2.30cm , Length: 23.50cm
Weight:   0.444kg
ISBN:  

9781617797262


ISBN 10:   161779726
Pages:   272
Publication Date:   19 April 2013
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Part 1.        Basic concepts       Chapter 1.      Issues in Translation of Pharmacogenomics into Clinical Practice.                         Kiang-Teck J. Yeo, Nikolina Babic, Alan H.B. Wu Chapter 2.      Molecular Diagnostic Methods in Pharmacogenomics                        Nikolina Babic*, Loren J. Joseph, Kiang-Teck J. Yeo Chapter 3.      Economics of pharmacogenomic testing in clinical practice                         Alan H.B. Wu Chapter 4.      From Personalized Medicine to Personalized Justice: The Promises of Translational Pharmacogenomics in the Justice System Steven H.Y. Wong, Christopher Happy, Daniel Blinka, Susan Goch, Jeffrey M. Jensen, Joseph M. Donald, Howard Coleman, Saeed A. Jortani, Yolanda Lurie, Cynthia L. Morris-Kukoski, Manuela G. Newman, Paul J. Orsulak, Tara Sander, Michael A. Wagner, Jennifer R. Wynn, Alan H.B. Wu, Kiang-Teck J. Yeo.   Part 2.        Specific pharmacogenomic targets: Chemotherapeutics Chapter 5.      Irinotecan R. Stephanie Huang, Federico Innocenti and Mark J. Ratain Chapter 6.      Pharmacogenomics of tamoxifen Christine LH Snozek, Alicia Algeciras-Schimnich, Matthew P Goetz, Loralie J Langman Chapter 7.      Thiopurines Terreia S. Jones, Mary V. Relling   Part 3.       Specific pharmacogenomic targets: Cardiovascular drugs Chapter 8.      The Pharmacogenetics of Vitamin K Antagonist Anticoagulation Drugs Charles Eby Chapter 9.      Clopidogrel and Salicylates Janice Y Chyou, Marc S Sabatine Chapter 10.    DNA-Guided Statin Therapy Gualberto Ruaño, Richard L. Seip, Jorge Duconge Chapter 11.    The statin response gene: Kif6 ....................... H. Robert Superko, Tom White, James Forrester, Spencer King III.   Part 4.        Drugs that cause delayed hypersensitivity Chapter 12.    Abacavir Elizabeth J. Phillips, Simon A. Mallal Chapter 13.    Allopurinol Pei Chen, Shuen-Iu Hung, Shih-Yang Chen, Yuan-Tsong Chen Chapter 14.    Carbamazepine and its structurally-related antiepiletics Shuen-Iu Hung, Wen-Hung Chung, Jing-Jane Tsai, Yuan-Tsong Chen Part 5........ Miscellaneous drugs Chapter 15.    Pharmacogenetics of Flucloxacillin and Amoxicillin-Clavulanate Associated Hepatic Dysfunction/Injury Hong-Kee Lee, Lionel D. Lewis Chapter 16.    Immunosuppressants Pharmacogenomics                         Ping Wang Steven H.Y. Wong, Christopher Happy, Daniel Blinka, Susan Goch, Jeffrey M. Jensen, Joseph M. Donald, Howard Coleman, Saeed A. Jortani, Yolanda Lurie, Cynthia L. Morris-Kukoski, Manuela G. Newman, Paul J. Orsulak, Tara Sander, Michael A. Wagner, Jennifer R. Wynn, Alan H.B. Wu, Kiang-Teck J. Yeo.   Part 2.        Specific pharmacogenomic targets: Chemotherapeutics Chapter 5.      Irinotecan R. Stephanie Huang, Federico Innocenti and Mark J. Ratain Chapter 6.      Pharmacogenomics of tamoxifen Christine LH Snozek, Alicia Algeciras-Schimnich, Matthew P Goetz, Loralie J Langman Chapter 7.      Thiopurines Terreia S. Jones, Mary V. Relling   Part 3.        Specific pharmacogenomic targets: Cardiovascular drugs Chapter 8.      The Pharmacogenetics of Vitamin K Antagonist Anticoagulation Drugs Charles Eby Chapter 9.      Clopidogrel and Salicylates Janice Y Chyou, Marc S Sabatine Chapter 10.    DNA-Guided Statin Therapy Gualberto Ruaño, Richard L. Seip, Jorge Duconge Chapter 11.    The statin response gene: Kif6 ....................... H. Robert Superko, Tom White, James Forrester, Spencer King III.   Part 4.        Drugs that cause delayed hypersensitivity Chapter12.    Abacavir Elizabeth J. Phillips, Simon A. Mallal Chapter 13.    Allopurinol Pei Chen, Shuen-Iu Hung, Shih-Yang Chen, Yuan-Tsong Chen Chapter 14.    Carbamazepine and its structurally-related antiepiletics Shuen-Iu Hung, Wen-Hung Chung, Jing-Jane Tsai, Yuan-Tsong Chen Part 5........ Miscellaneous drugs Chapter 15.    Pharmacogenetics of Flucloxacillin and Amoxicillin-Clavulanate Associated Hepatic Dysfunction/Injury Hong-Kee Lee, Lionel D. Lewis Chapter 16.    Immunosuppressants Pharmacogenomics                         Ping Wang Chapter 14.    Carbamazepine and its structurally-related antiepiletics Shuen-Iu Hung, Wen-Hung Chung, Jing-Jane Tsai, Yuan-Tsong Chen Part 5........ Miscellaneous drugs Chapter 15.    Pharmacogenetics of Flucloxacillin and Amoxicillin-Clavulanate Associated Hepatic Dysfunction/Injury Hong-Kee Lee, Lionel D. Lewis Chapter 16.    Immunosuppressants Pharmacogenomics                         Ping Wang

Reviews

From the reviews: The book is written for clinical laboratory directors 'contemplating or assigned the task of establishing a pharmacogenomics laboratory,' pharmacologists, and interested clinicians who may have to interpret results. This book also would be of interest to ... allied health practitioners, regulators, reimbursers, and test device manufacturers. ... The writing is concise, clear, and accessible for what might be considered a complex topic. ... Get this book if you want a quick, concise, and fascinating read about the current world and use of pharmacogenomic testing. (Valerie L. Ng, Doody's Review Service, May, 2011)


From the reviews: The book is written for clinical laboratory directors `contemplating or assigned the task of establishing a pharmacogenomics laboratory,' pharmacologists, and interested clinicians who may have to interpret results. This book also would be of interest to ... allied health practitioners, regulators, reimbursers, and test device manufacturers. ... The writing is concise, clear, and accessible for what might be considered a complex topic. ... Get this book if you want a quick, concise, and fascinating read about the current world and use of pharmacogenomic testing. (Valerie L. Ng, Doody's Review Service, May, 2011)


Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List